<DOC>
	<DOCNO>NCT02406066</DOCNO>
	<brief_summary>This study EMB-001 ( combination two FDA-approved drug , metyrapone oxazepam ) otherwise healthy adult regular cigarette smoker . There 3 group 8 subject ; group , 6 subject get drug combination 2 get placebo . Neither subject study personnel know get drug get placebo ( double-blind ) . In first group drug dose low , increased second third group . Subjects receive single dose Day 1 , follow 24 hour later start dos twice daily 7 day , final morning dose last day . The level drug blood assess repeat blood draw first day end dosing . Safety assess single dose repeat dose . Effects study drug smoke crave cigarette assessed end repeat dose . The hypothesis drug combination safe , relatively side effect .</brief_summary>
	<brief_title>Single Multiple Rising Dose Study Safety PK Metyrapone/Oxazepam Combination ( EMB-001 )</brief_title>
	<detailed_description>This study Phase 1 , double blind , single multiple rise dose tolerance study EMB-001 ( metyrapone/oxazepam combination ) otherwise healthy adult tobacco use disorder . There 3 cohort , 8 subject ( 6 active : 2 placebo ) , total 24 subject . During treatment period , subject receive single dose EMB 001 Day 1 , follow 24 hour later start multiple dos twice daily 7 day , final morning dose last dosing day ( Day 9 ) . This design allow characterization EMB-001 single dose PK 24 hour , follow assessment repeat dose PK multiple-dose phase . Safety assess single dose repeat dose . Effects study drug smoke crave cigarette assessed end repeat dose . Later study may also assess efficacy drug combination treat cocaine use disorder , tobacco use disorder , and/or disorder .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Metyrapone</mesh_term>
	<mesh_term>Oxazepam</mesh_term>
	<criteria>Males female NonChildbearing Potential age 1865 Have provide write informed consent prior study procedure Are willing able comply aspect protocol Normal clinically acceptable screen electrocardiogram ( ECG ) Normal blood pressure ( systolic : 90140 mmHg ; diastolic 5090 mmHg ) heart rate ( 50100 bpm ) Smoke least 10 cigarette per day ( approximately 1 year longer ) Body mass index &gt; 18.5 &lt; 35 Known hypersensitivity intolerance oxazepam metyrapone , benzodiazepine Subjects low outofrange serum cortisol value screen subject , investigator 's opinion , heighten likelihood adrenal insufficiency . Subjects positive urine drug screen illegal drug drug high potential abuse ( nicotine ) . Inability communicate cooperate investigator History drug dependence ( except nicotine ) psychiatric illness within past 2 year . Subjects history adrenal insufficiency adrenal , hypothalamic , pituitary disorder . History asthma respiratory disease , neurologic neuromuscular disease , hypotension cardiovascular disease , may , opinion investigator , impact study procedure measure , compromise safety subject . Other severe , acute , chronic medical psychiatric condition laboratory abnormality may increase risk associate trial participation investigational product administration may interfere interpretation trial result , judgment Investigator Sponsor , would make subject inappropriate entry trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>